Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

BACKGROUND: We conducted a randomized comparison of hydroxyurea with anagrelide in the treatment of essential thrombocythemia. METHODS: A total of 809 patients with essential thrombocythemia who were at high risk for vascular events received low-dose aspirin plus either anagrelide or hydroxyurea. Th...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Harrison, C, Campbell, P, Buck, G, Wheatley, K, East, C, Bareford, D, Wilkins, B, van der Walt, JD, Reilly, J, Grigg, A, Revell, P, Woodcock, B, Green, A
פורמט:	Journal article
שפה:	English
יצא לאור:	2005

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

פריטים דומים